Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins | 10 | 2024 | 625 | 3.070 |
Why?
|
| DNA-Binding Proteins | 10 | 2024 | 2178 | 2.180 |
Why?
|
| 5-Methylcytosine | 6 | 2023 | 34 | 1.570 |
Why?
|
| Pluripotent Stem Cells | 3 | 2020 | 80 | 1.180 |
Why?
|
| Cell Differentiation | 10 | 2023 | 2044 | 1.150 |
Why?
|
| Octamer Transcription Factor-3 | 3 | 2020 | 45 | 0.900 |
Why?
|
| Folic Acid | 1 | 2024 | 297 | 0.770 |
Why?
|
| Cell Lineage | 3 | 2020 | 371 | 0.760 |
Why?
|
| beta Catenin | 1 | 2023 | 232 | 0.730 |
Why?
|
| Embryonic Development | 3 | 2024 | 225 | 0.700 |
Why?
|
| DNA Demethylation | 1 | 2020 | 10 | 0.660 |
Why?
|
| DNA Methylation | 8 | 2024 | 1148 | 0.600 |
Why?
|
| Embryonic Stem Cells | 5 | 2017 | 178 | 0.590 |
Why?
|
| Germ Layers | 4 | 2023 | 10 | 0.560 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 232 | 0.550 |
Why?
|
| Cytosine | 3 | 2013 | 59 | 0.520 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2024 | 1051 | 0.480 |
Why?
|
| Brain | 2 | 2024 | 3226 | 0.440 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2015 | 171 | 0.440 |
Why?
|
| Mice | 15 | 2024 | 19045 | 0.410 |
Why?
|
| Promoter Regions, Genetic | 2 | 2015 | 1434 | 0.360 |
Why?
|
| Animals | 19 | 2025 | 36521 | 0.360 |
Why?
|
| Cellular Reprogramming | 2 | 2025 | 130 | 0.350 |
Why?
|
| Endoderm | 2 | 2023 | 24 | 0.340 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 390 | 0.270 |
Why?
|
| DNA | 2 | 2009 | 1685 | 0.260 |
Why?
|
| Arteries | 2 | 2006 | 231 | 0.260 |
Why?
|
| Transplantation, Homologous | 2 | 2006 | 653 | 0.250 |
Why?
|
| Epigenesis, Genetic | 3 | 2024 | 771 | 0.250 |
Why?
|
| Interferon-gamma | 2 | 2006 | 536 | 0.240 |
Why?
|
| Folic Acid Deficiency | 1 | 2024 | 52 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 4882 | 0.220 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 177 | 0.220 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 2023 | 8 | 0.210 |
Why?
|
| Endothelial Cells | 2 | 2023 | 539 | 0.210 |
Why?
|
| Genomics | 2 | 2023 | 1678 | 0.200 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2023 | 33 | 0.200 |
Why?
|
| Urethra | 1 | 2023 | 90 | 0.200 |
Why?
|
| Pregnancy | 4 | 2024 | 7600 | 0.200 |
Why?
|
| Automobile Driving | 1 | 2023 | 34 | 0.200 |
Why?
|
| Wnt Signaling Pathway | 1 | 2023 | 208 | 0.190 |
Why?
|
| Rhabdomyosarcoma | 1 | 2025 | 211 | 0.180 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 524 | 0.180 |
Why?
|
| Transcription Factors | 3 | 2020 | 2735 | 0.180 |
Why?
|
| Neural Tube Defects | 1 | 2024 | 359 | 0.180 |
Why?
|
| T-Lymphocytes | 3 | 2006 | 1772 | 0.160 |
Why?
|
| Uterine Diseases | 1 | 2019 | 25 | 0.160 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 158 | 0.150 |
Why?
|
| Epigenomics | 1 | 2020 | 196 | 0.150 |
Why?
|
| CpG Islands | 3 | 2015 | 347 | 0.150 |
Why?
|
| Endometrial Neoplasms | 1 | 2019 | 116 | 0.140 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 467 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2025 | 949 | 0.140 |
Why?
|
| Gastrula | 1 | 2017 | 22 | 0.140 |
Why?
|
| Ectoderm | 1 | 2017 | 32 | 0.140 |
Why?
|
| Binding Sites | 2 | 2011 | 1386 | 0.130 |
Why?
|
| Crosses, Genetic | 1 | 2017 | 170 | 0.130 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 30 | 0.130 |
Why?
|
| Telomere Homeostasis | 1 | 2017 | 47 | 0.130 |
Why?
|
| Catalysis | 1 | 2017 | 139 | 0.130 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2017 | 32 | 0.130 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 139 | 0.130 |
Why?
|
| Gene Deletion | 1 | 2020 | 811 | 0.130 |
Why?
|
| Dioxygenases | 3 | 2013 | 65 | 0.130 |
Why?
|
| Cell Line | 4 | 2017 | 2863 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2020 | 3180 | 0.130 |
Why?
|
| Mice, Knockout | 1 | 2024 | 4012 | 0.130 |
Why?
|
| Chromatin | 1 | 2020 | 617 | 0.130 |
Why?
|
| Organoids | 1 | 2019 | 300 | 0.130 |
Why?
|
| Gene Dosage | 1 | 2017 | 458 | 0.120 |
Why?
|
| Oxidation-Reduction | 2 | 2013 | 468 | 0.120 |
Why?
|
| Transcription Initiation Site | 1 | 2015 | 34 | 0.120 |
Why?
|
| HEK293 Cells | 2 | 2015 | 825 | 0.120 |
Why?
|
| Sequence Deletion | 1 | 2017 | 541 | 0.110 |
Why?
|
| NIH 3T3 Cells | 1 | 2015 | 97 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 2538 | 0.110 |
Why?
|
| Hydroxylation | 2 | 2010 | 51 | 0.110 |
Why?
|
| Signal Transduction | 3 | 2025 | 4936 | 0.100 |
Why?
|
| Transcriptome | 1 | 2020 | 1135 | 0.100 |
Why?
|
| Gestational Age | 1 | 2017 | 1230 | 0.100 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 124 | 0.100 |
Why?
|
| Cell Cycle | 2 | 2025 | 624 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 787 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 249 | 0.080 |
Why?
|
| Mutant Proteins | 1 | 2010 | 120 | 0.080 |
Why?
|
| Blastocyst | 2 | 2023 | 79 | 0.080 |
Why?
|
| Consensus Sequence | 1 | 2009 | 59 | 0.080 |
Why?
|
| Genome | 1 | 2013 | 529 | 0.080 |
Why?
|
| Tandem Repeat Sequences | 1 | 2009 | 38 | 0.080 |
Why?
|
| Female | 5 | 2024 | 72035 | 0.080 |
Why?
|
| Teratoma | 1 | 2011 | 131 | 0.080 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2010 | 128 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1762 | 0.080 |
Why?
|
| Base Sequence | 2 | 2013 | 3180 | 0.080 |
Why?
|
| Histones | 1 | 2013 | 572 | 0.080 |
Why?
|
| Point Mutation | 1 | 2009 | 362 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 2793 | 0.070 |
Why?
|
| Structure-Activity Relationship | 1 | 2009 | 610 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 3978 | 0.070 |
Why?
|
| Transplantation, Heterologous | 2 | 2006 | 276 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2006 | 615 | 0.060 |
Why?
|
| Humans | 12 | 2025 | 134194 | 0.060 |
Why?
|
| Computational Biology | 1 | 2011 | 890 | 0.060 |
Why?
|
| Cyclosporine | 1 | 2006 | 128 | 0.060 |
Why?
|
| Protein Binding | 1 | 2009 | 1860 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2010 | 572 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2009 | 874 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2004 | 93 | 0.050 |
Why?
|
| Glycolysis | 1 | 2025 | 173 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 147 | 0.050 |
Why?
|
| Sirolimus | 1 | 2006 | 239 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2004 | 117 | 0.050 |
Why?
|
| Cell Communication | 1 | 2004 | 192 | 0.050 |
Why?
|
| Parturition | 1 | 2023 | 67 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 695 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 508 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 445 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2025 | 795 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2023 | 1308 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2019 | 295 | 0.040 |
Why?
|
| Angiopoietin-1 | 1 | 2017 | 7 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3800 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2025 | 2137 | 0.030 |
Why?
|
| Endometrium | 1 | 2019 | 290 | 0.030 |
Why?
|
| Rats | 1 | 2023 | 3876 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2023 | 1922 | 0.030 |
Why?
|
| Male | 1 | 2020 | 66195 | 0.030 |
Why?
|
| U937 Cells | 1 | 2013 | 25 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 149 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2013 | 181 | 0.020 |
Why?
|
| Caspases | 1 | 2013 | 168 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 4802 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 651 | 0.020 |
Why?
|
| Biocatalysis | 1 | 2010 | 36 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 718 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2010 | 320 | 0.020 |
Why?
|
| Dinucleoside Phosphates | 1 | 2009 | 11 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2009 | 36 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 367 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2009 | 633 | 0.020 |
Why?
|
| RNA Interference | 1 | 2009 | 548 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 3433 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 1098 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 358 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 680 | 0.010 |
Why?
|
| Cell Movement | 1 | 2004 | 920 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 6350 | 0.010 |
Why?
|